personalized medicine

Tumor Location an Influencer of Survival in Patients With Colorectal Cancer

06/04/2016

JCP Editors

The physical location of a primary tumor may be an indicator of survivor in patients with metastatic colorectal cancer (mCRC), according to results from a large retrospective study presented at the American Society...

The...

06/04/2016

Journal of Clinical Pathways

Research in Review

Pancreatic Cancer Resources Available Online Inaccurate and Difficult to Read

05/13/2016

JCP Editors

Online materials about pancreatic cancer may lack accurate information about alternative therapy and be too complicated to benefit patients with the disease, claims a recent study. The readability and accuracy of...

Online...

05/13/2016

Journal of Clinical Pathways

Oncology Nurse Navigators Improve GI Cancer Outcomes

04/28/2016

JCP Editors

At the second annual Oncology Nurse Advisor Navigation Summit (April 7-9, 2016; Orlando, FL), Teresa Labovich, MSN, RN, OCN, Penrose Cancer Center (Colorado Springs, CO), described a method by which gastrointestinal...

At the...

04/28/2016

Journal of Clinical Pathways

Interview

Devising Pathways Strategies That Maintain the Principles of Personalized Medicine

04/11/2016

JCP Editors

As clinical pathways are utilized by more institutions to provide standardized, evidence-based care for patients with cancer, these tools have demonstrated a clear ability to reduce costs,1 improve hospital...

As...

04/11/2016

Journal of Clinical Pathways

Value and Precision Medicine

04/11/2016

JCP Editors

During her presentation at CANCERSCAPE, Kavita Patel, MD, MS, senior fellow at the Brookings Institution (Washington, DC), explained that, to physicians, personalized medicine doesn’t seem like something you have to...

During...

04/11/2016

Journal of Clinical Pathways

New NCCN Guidelines Advise More Physician-led Discussions of Sexual Dysfunction

04/07/2016

JCP Editors

Clinicians should take a more active role in discussing sexual dysfunction with their patients, according to updates to National Comprehensive Cancer Network (NCCN) guidelines, which were presented at the NCCN annual...

...

04/07/2016

Journal of Clinical Pathways

Oncologists Call for New Metrics to Evaluate Effectiveness of Novel Treatments

03/17/2016

JCP Editors

At the 33rd Annual Miami Breast Cancer Conference (March 10-11, 2016; Miami Beach, FL), presenters called for new ways to evaluate the success of novel agents for the treatment of breast cancer. Although overall...

At the...

03/17/2016

Journal of Clinical Pathways

Research in Review

Use of MRI Influences Physician Decision-Making in Prostate Cancer

03/10/2016

JCP Editors

A study of prostate cancer has found that MRI (magnetic resource imaging) evaluations can influence clinical decision-making for both physicians and patients, though whether those decisions result in superior...

A...

03/10/2016

Journal of Clinical Pathways

Research in Review

Treatment Pattern Mining to Account for Comorbidities During Clinical Pathway Execution

02/16/2016

JCP Editors

A study conducted by a group of Chinese researchers has shown that incorporating latent treatment pattern mining during clinical pathway execution can help clinicians better account for comorbidities likely to...

...

02/16/2016

Journal of Clinical Pathways

Research in Review

Personalized Genomic Framework Predicts Treatment Outcomes in AML

12/10/2015

JCP Editors

Researchers have developed a novel prognostic framework using genomic sequencing data to assess risk in patients with acute myeloid leukemia (AML). Their work was presented at the American Society of Hematology (ASH)...

...

12/10/2015

Journal of Clinical Pathways